Lipitor lawsuits filed in federal courts on behalf of people who developed type 2 diabetes after taking Pfizer’s cholesterol-lowering statin, also called atorvastatin, were consolidated in the District of South Carolina on February 18, 2014. By consolidating lawsuits from across the United States into a mass tort, the court will be able to conserve resources, avoid duplication of discovery, and prevent inconsistent pretrial rulings.
A study conducted by the Women’s Health Initiative of 150,000 postmenopausal women found that those taking a statin were 48 percent more likely to get a diabetes diagnosis. The statistic rose to 86% for women with a low BMI – basically, women with normal body weight.
Pfizer has known since 1996 that the drug carried a risk of diabetes, but only started warning doctors and patients about the risk when it was forced to by the FDA in 2012. With adequate warnings and information about this side effect, doctors could have been monitoring patients’ glucose levels for signs of diabetes. Unfortunately, this didn’t happen.
Thousands of women who now have type 2 diabetes may unknowingly be victims of Lipitor. Studies have shown that the danger is particularly high in women with existing risk factors including:
Pharmaceutical attorneys at Janet, Jenner & Suggs are national leaders in the field of dangerous drug and device litigation. Attorney Kenneth Suggs, who is representing plaintiffs in these cases, he has been recognized as one of the nation’s finest trial lawyers. If you were prescribed high doses of Lipitor and have since been diagnosed with type 2 diabetes, our attorneys can review your case and offer guidance. You may be eligible to join a lawsuit and help prevent others from being harmed by unsafe drugs.